Literature DB >> 29892819

Thyroid Hormones and Derivatives: Endogenous Thyroid Hormones and Their Targets.

Josef Köhrle1.   

Abstract

More than a century after the discovery of L-Thyroxine, the main thyroid hormone secreted solely by the thyroid gland, several metabolites of this iodinated, tyrosine-derived ancestral hormone have been identified. These are utilized as hormones during development, differentiation, metamorphosis, and regulation of most biochemical reactions in vertebrates and their precursor species. Among those metabolites are the thyromimetically active 3,3',5-Triiodo-L-thyronine (T3) and 3,5-Diiodo-L-thronine, reverse-T3 (3,3',5'-Triiodo-L-thyronine) with still unclear function, the recently re-discovered thyronamines (e.g., 3-Iodo-thyronamine), which exert in part T3-antagonistic functions, the thyroacetic acids (e.g., Tetrac and Triac), as well as various sulfated or glucuronidated metabolites of this panel of iodinated signaling compounds. In the blood most of these hydrophobic metabolites are tightly bound to the serum distributor proteins thyroxine binding globulin (TBG), transthyretin (TTR), albumin or apolipoprotein B100. Cellular import and export of these charged, highly hydrophobic amino acid derivatives requires a number of cell-membrane transporters or facilitators such as MCT8 or MCT10 and members of the OATP and LAT families of transporters. Depending on their structure, the thyroid hormone metabolites exert their cellular action by binding and thus modulating the function of various receptors systems (e.g., ανβ3 integrin receptor and transient receptor potential channels (TRPM8) of the cell membrane), in part linked to intracellular downstream kinase signaling cascades, and several isoforms of membrane-associated, mitochondrial or nuclear thyroid hormone receptors (TR), which are members of the c-erbA family of ligand-modulated transcription factors. Intracellular deiodinase selenoenzymes, which obligatory are membrane integrated enzymes, ornithine decarboxylase and monoamine oxidases control local availability of biologically active thyroid hormone metabolites. Inactivation of thyroid hormone metabolites occurs mainly by deiodination, sulfation or glucuronidation, reactions which favor their renal or fecal elimination.

Entities:  

Keywords:  Analogue; Conjugation; Deiodinase; Immunoassay; Inhibitor; Iodothyronine; Mass spectrometry; Monoamine oxidase; Ornithine decarboxylase; Thyroacetic acid; Thyroid hormone; Thyronamine; Thyronome

Mesh:

Substances:

Year:  2018        PMID: 29892819     DOI: 10.1007/978-1-4939-7902-8_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

Review 1.  Hypothyroidism.

Authors:  Layal Chaker; Salman Razvi; Isabela M Bensenor; Fereidoun Azizi; Elizabeth N Pearce; Robin P Peeters
Journal:  Nat Rev Dis Primers       Date:  2022-05-19       Impact factor: 52.329

2.  Characterization of Thyroid Hormones Antivertigo Effects in a Rat Model of Excitotoxically-Induced Vestibulopathy.

Authors:  Claire M Bringuier; Bérenice Hatat; Romain Boularand; Christian Chabbert; Brahim Tighilet
Journal:  Front Neurol       Date:  2022-05-25       Impact factor: 4.086

3.  TSH adenoma and syndrome of resistance to thyroid hormones-Two cases report of syndrome of inappropriate secretion of thyrotropin.

Authors:  Fang Deng; Ze-Yu Yang; Yu-Ping Zhang; Yu-Lin Wang; Jiong-Yu Hu; Fan Zhang
Journal:  Brain Behav       Date:  2021-03-10       Impact factor: 2.708

Review 4.  Transcription, Processing, and Decay of Mitochondrial RNA in Health and Disease.

Authors:  Arianna Barchiesi; Carlo Vascotto
Journal:  Int J Mol Sci       Date:  2019-05-06       Impact factor: 5.923

Review 5.  Thyroid Hormone Distributor Proteins During Development in Vertebrates.

Authors:  Sarah A Rabah; Indra L Gowan; Maurice Pagnin; Narin Osman; Samantha J Richardson
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-08       Impact factor: 5.555

Review 6.  Pesticides With Potential Thyroid Hormone-Disrupting Effects: A Review of Recent Data.

Authors:  Michelle Leemans; Stephan Couderq; Barbara Demeneix; Jean-Baptiste Fini
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-09       Impact factor: 5.555

7.  A Thyroid Hormone-Independent Molecular Fingerprint of 3,5-Diiodothyronine Suggests a Strong Relationship with Coffee Metabolism in Humans.

Authors:  Maik Pietzner; Josef Köhrle; Ina Lehmphul; Kathrin Budde; Gabi Kastenmüller; Georg Brabant; Henry Völzke; Anna Artati; Jerzy Adamski; Uwe Völker; Matthias Nauck; Nele Friedrich; Georg Homuth
Journal:  Thyroid       Date:  2019-11-11       Impact factor: 6.568

8.  3,5-T2-A Janus-Faced Thyroid Hormone Metabolite Exerts Both Canonical T3-Mimetic Endocrine and Intracrine Hepatic Action.

Authors:  Josef Köhrle; Ina Lehmphul; Maik Pietzner; Kostja Renko; Eddy Rijntjes; Keith Richards; João Anselmo; Mark Danielsen; Jacqueline Jonklaas
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-08       Impact factor: 5.555

9.  Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models.

Authors:  Hyeok Jun Yun; Hee Jun Kim; Jungmin Kim; Sang Yong Kim; Hang-Seok Chang; Cheong Soo Park; Ho-Jin Chang; Ki Cheong Park
Journal:  Int J Mol Sci       Date:  2021-01-07       Impact factor: 5.923

Review 10.  Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders.

Authors:  Federica Saponaro; Simona Sestito; Massimiliano Runfola; Simona Rapposelli; Grazia Chiellini
Journal:  Front Med (Lausanne)       Date:  2020-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.